Biotech

All Articles

8 months after a $213M fundraise, genetics editor Volume produces decreases

.After increasing $213 million in 2023-- among the year's biggest private biotech shots-- Tome Biosc...

BioMarin develops director staff with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings as wel...

Biopharma Q2 VC struck highest degree because '22, while M&ampA slowed

.Equity capital financing right into biopharma rose to $9.2 billion throughout 215 handle the second...

Bicara, Zenas find IPOs to drive late-phase possessions toward market

.Bicara Therapies and also Zenas Biopharma have actually offered fresh inspiration to the IPO market...

Genentech to finalize cancer cells immunology research study division

.Genentech will certainly close its cancer cells immunology study division, and also device mind as ...

Kezar goes down sound lump yet to verify its own worth in period 1 test

.Kezar Lifestyle Sciences is losing its own unpromising stage 1 solid growth medication as the biote...

Acelyrin loses izokibep, lays off 3rd of personnel

.Even with izokibep maintaining its own newfound winning touch in the clinic, Acelyrin is actually n...

Rivus' period 2 obesity-related heart failure test hits endpoint

.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing drug appl...

Ovid standstills preclinical work, IV program after soticlestat fail

.Ovid Rehab presently revealed last month that it was trimming back its own headcount as the company...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has opened a $700 million R&ampD facility in the Boston Port, boosting its own RNA and DN...